Genetics
Decoding Multiple Sclerosis Risk Through Multi-Omics and Machine Learning05, May 2026
02, May 2026
01, May 2026
Alper Bülbül
05, May 2026
This blog post examines a recent scientific study that integrates genome-wide association data with brain transcriptomic, splicing, proteomic, and immune-expression datasets to identify candidate genes involved in multiple sclerosis risk. The article highlights how multi-omics analysis and machine learning prioritized a 10-gene predictive signature and identified ZC2HC1A and TRAF3 as especially promising biomarkers and mechanistic candidates. By linking genetic regulation to immune pathways such as lymphocyte activation, NF-κB signaling, Epstein–Barr virus-related mechanisms, and CD4+ T-cell activity, the study offers a deeper view of the molecular architecture underlying multiple sclerosis and points toward future diagnostic and therapeutic opportunities.
Read more02, May 2026
01, May 2026
30, Apr 2026
